The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.

AusPAR: Ivermectin

Australian Public Assessment Report

AusPAR

AusPAR: Ivermectin [PDF, 809.01 KB]

AusPAR: Ivermectin [Word, 624.45 KB]

Attachment: Product Information 1: Ivermectin [PDF, 324.45 KB]

Attachment: Product Information 1: Ivermectin [Word, 257.99 KB]

Attachment: Product Information 2: Ivermectin [PDF, 347 KB]

Attachment: Product Information 2: Ivermectin [Word, 256.45 KB]

Attachment: Extract from the Clinical Evaluation Report: Ivermectin [PDF, 1.8 MB]

Attachment: Extract from the Clinical Evaluation Report: Ivermectin [Word, 3.12 MB]

Device/Product Name

Soolantra / Vastreka

Active ingredients

Ivermectin

AusPAR Date

9 December 2015

Published

5 January 2016

Submission Number

PM-2014-01877-1-2

Submission Type

Major variation (new dose form, new indications)

Decision

Approved